Home
/
Eloxx Pharmaceuticals, Inc.
/
Financials
/
Quarterly
Eloxx Pharmaceuticals, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Eloxx Pharmaceuticals, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2013
Dec 31, 2012
$0
Feb 14, 2013
Q1
2013
Sep 30, 2012
$1.79M
Nov 14, 2012
Q3
2012
Mar 31, 2012
$200.0K
May 14, 2012
Q2
2013
Dec 31, 2011
$200.0K
Feb 14, 2013
Q1
2012
Sep 30, 2011
$1.59M
Nov 14, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
($3.59M)
Nov 13, 2023
Q2
2023
Jun 30, 2023
($4.34M)
Aug 11, 2023
Q3
2023
Jun 30, 2023
($4.34M)
Nov 13, 2023
Q1
2023
Mar 31, 2023
($6.23M)
May 12, 2023
Q3
2023
Mar 31, 2023
($6.23M)
Nov 13, 2023
Q2
2023
Mar 31, 2023
($6.23M)
Aug 11, 2023
Q3
2023
Sep 30, 2022
($7.51M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($10.62M)
Aug 11, 2023
Q3
2023
Jun 30, 2022
($10.62M)
Nov 13, 2023
Q1
2023
Mar 31, 2022
($11.62M)
May 12, 2023
Q3
2023
Mar 31, 2022
($11.62M)
Nov 13, 2023
Q2
2023
Mar 31, 2022
($11.62M)
Aug 11, 2023
Q3
2022
Sep 30, 2021
($9.89M)
Nov 10, 2022
Q3
2022
Jun 30, 2021
($36.06M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($36.06M)
Aug 12, 2022
Q3
2022
Mar 31, 2021
($8.69M)
Nov 10, 2022
Q1
2022
Mar 31, 2021
($8.69M)
May 6, 2022
Q2
2022
Mar 31, 2021
($8.69M)
Aug 12, 2022
Q3
2021
Sep 30, 2020
($6.62M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($7.89M)
Aug 16, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
($3.64M)
Nov 13, 2023
Q2
2023
Jun 30, 2023
($4.14M)
Aug 11, 2023
Q1
2023
Mar 31, 2023
($5.48M)
May 12, 2023
Q3
2023
Sep 30, 2022
($7.14M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($10.30M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($10.95M)
May 12, 2023
Q3
2022
Sep 30, 2021
($10.25M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($35.73M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($8.41M)
May 6, 2022
Q3
2021
Sep 30, 2020
($6.30M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($7.59M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($13.77M)
May 7, 2021
Q3
2020
Sep 30, 2019
($12.78M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($14.31M)
Aug 7, 2020
Q1
2020
Mar 31, 2019
($11.98M)
May 8, 2020
Q3
2019
Sep 30, 2018
($11.36M)
Nov 6, 2019
Q2
2019
Jun 30, 2018
($13.54M)
Aug 7, 2019
Q1
2019
Mar 31, 2018
($8.55M)
May 9, 2019
Q3
2018
Sep 30, 2017
($4.00M)
Nov 8, 2018
Q1
2018
Sep 30, 2017
($627.4K)
Nov 14, 2017